Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Antonioli

Showing results (41-50 of 179) with videos related to

Pageof 18
Sort By:
Medicinal Research Reviews|January 18, 2021
NLRP3 inflammasome in cardiovascular diseases: Pathophysiological and pharmacological implicationsCarolina Pellegrini, Alma Martelli, Luca Antonioli, et al.
Trends in Molecular Medicine|July 1, 2020
Ectopic Lymphoid Organs and Immune-Mediated Diseases: Molecular Basis for Pharmacological ApproachesLuca Antonioli, Matteo Fornai, Carolina Pellegrini, et al.
Expert Opinion on Biological Therapy|November 22, 2018
Risankizumab for the treatment of moderate to severe psoriasisAndrea Chiricozzi, Luca Antonioli, Salvatore Panduri, et al.
Nutrition Research Reviews|June 7, 2018
Dietary flavonoids as a potential intervention to improve redox balance in obesity and related co-morbidities: a reviewDaniela Gentile, Matteo Fornai, Carolina Pellegrini, et al.
International Journal of Molecular Sciences|July 26, 2020
The Adenosine System at the Crossroads of Intestinal Inflammation and NeoplasiaVanessa D'Antongiovanni, Matteo Fornai, Carolina Pellegrini, et al.
Current Opinion in Pharmacology|March 29, 2019
P2X4 receptors, immunity, and sepsisLuca Antonioli, Corrado Blandizzi, Matteo Fornai, et al.
Frontiers in Immunology|August 28, 2020
Inflammatory Bowel Diseases: It's Time for the Adenosine SystemLuca Antonioli, Matteo Fornai, Carolina Pellegrini, et al.
Inflammatory Bowel Diseases|January 25, 2006
A2a receptors mediate inhibitory effects of adenosine on colonic motility in the presence of experimental colitisLuca Antonioli, Matteo Fornai, Rocchina Colucci, et al.
Frontiers in Pharmacology|March 30, 2018
Purinergic Ligands as Potential Therapeutic Tools for the Treatment of Inflammation-Related Intestinal DiseasesDiego Dal Ben, Luca Antonioli, Catia Lambertucci, et al.
Frontiers in Immunology|April 5, 2017
Roles and Modalities of Ectonucleotidases in Remodeling the Multiple Myeloma NicheAntonella Chillemi, Valeria Quarona, Luca Antonioli, et al.
Pageof 18

Showing results (41-50 of 179) with videos related to

Sort By:
Pageof 18
Medicinal Research Reviews|January 18, 2021
NLRP3 inflammasome in cardiovascular diseases: Pathophysiological and pharmacological implicationsCarolina Pellegrini, Alma Martelli, Luca Antonioli, et al.
Trends in Molecular Medicine|July 1, 2020
Ectopic Lymphoid Organs and Immune-Mediated Diseases: Molecular Basis for Pharmacological ApproachesLuca Antonioli, Matteo Fornai, Carolina Pellegrini, et al.
Expert Opinion on Biological Therapy|November 22, 2018
Risankizumab for the treatment of moderate to severe psoriasisAndrea Chiricozzi, Luca Antonioli, Salvatore Panduri, et al.
Nutrition Research Reviews|June 7, 2018
Dietary flavonoids as a potential intervention to improve redox balance in obesity and related co-morbidities: a reviewDaniela Gentile, Matteo Fornai, Carolina Pellegrini, et al.
International Journal of Molecular Sciences|July 26, 2020
The Adenosine System at the Crossroads of Intestinal Inflammation and NeoplasiaVanessa D'Antongiovanni, Matteo Fornai, Carolina Pellegrini, et al.
Current Opinion in Pharmacology|March 29, 2019
P2X4 receptors, immunity, and sepsisLuca Antonioli, Corrado Blandizzi, Matteo Fornai, et al.
Frontiers in Immunology|August 28, 2020
Inflammatory Bowel Diseases: It's Time for the Adenosine SystemLuca Antonioli, Matteo Fornai, Carolina Pellegrini, et al.
Inflammatory Bowel Diseases|January 25, 2006
A2a receptors mediate inhibitory effects of adenosine on colonic motility in the presence of experimental colitisLuca Antonioli, Matteo Fornai, Rocchina Colucci, et al.
Frontiers in Pharmacology|March 30, 2018
Purinergic Ligands as Potential Therapeutic Tools for the Treatment of Inflammation-Related Intestinal DiseasesDiego Dal Ben, Luca Antonioli, Catia Lambertucci, et al.
Frontiers in Immunology|April 5, 2017
Roles and Modalities of Ectonucleotidases in Remodeling the Multiple Myeloma NicheAntonella Chillemi, Valeria Quarona, Luca Antonioli, et al.
Pageof 18